IFRX - InflaRx N.V. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

151.9M

Cash

24.71M

Avg Qtr Burn

-7.517M

Short % of Float

0.42%

Insider Ownership

13.10%

Institutional Own.

19.29%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Gohibic (vilobelimab) Details COVID-19	BLA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vilobelimab (IFX-1) Details Skin disease/disorder, Autoimmune disease	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vilobelimab (IFX-1) Details Cancer, Cutaneous squamous cell carcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INF904 (C5aR Inhibitor) Details Chronic Autoimmune and Inflammatory Diseases	Phase 1a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IFX-1 (vilobelimab) Details Skin disease/disorder, Hidradenitis suppurativa	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IFX-1 (vilobelimab) Details Autoimmune disease, Antineutrophil cytoplasmic antibody-associated vasculitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.